Nektar Therapeutics
NKTR
#5687
Rank
S$1.49 B
Marketcap
S$73.74
Share price
-1.37%
Change (1 day)
260.05%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.28 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are S$0.28 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.33 B-6.3%
2023-12-31S$0.35 B-23.51%
2022-12-31S$0.46 B-22.07%
2021-12-31S$0.59 B-3.08%
2020-12-31S$0.61 B-20.83%
2019-12-31S$0.77 B30.48%
2018-12-31S$0.59 B4.95%
2017-12-31S$0.56 B-19.06%
2016-12-31S$0.69 B-0.07%
2015-12-31S$0.69 B30.01%
2014-12-31S$0.53 B-19.4%
2013-12-31S$0.66 B20.53%
2012-12-31S$0.55 B4.14%
2011-12-31S$0.52 B-4.56%
2010-12-31S$0.55 B-16.51%
2009-12-31S$0.66 B25.41%
2008-12-31S$0.52 B-27.92%
2007-12-31S$0.73 B-11.44%
2006-12-31S$0.82 B-6.28%
2005-12-31S$0.88 B95.51%
2004-12-31S$0.45 B-41.11%
2003-12-31S$0.76 B10.83%
2002-12-31S$0.69 B-5.57%
2001-12-31S$0.73 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
S$104.34 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.85 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.61 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
S$52.74 M-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$88.74 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
S$17.95 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$0.77 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
S$147.13 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA